Frank Torti, future FDA chief?

From scientist-in-chief to top chief? Frank Torti, a cancer researcher who joined FDA two months ago, may be in line for the commissioner's job. Beltway wags say the current leader, Andrew von Eschenbach, is likely on his way out after the presidential election in November--no matter who wins. Torti could have the inside track: As scientist in chief, he'd be a logical choice for interim commissioner. And that's how von Eschenbach ended up in the job. Torti's only comment was noncommittal. “I’m not in the habit of taking a job no one’s told me about yet," he told the Pink Sheet. For a peek at his current policy plans, see the RPM Report's link.

- read the RPM Report story
- see the WSJ Health Blog item

Suggested Articles

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…